|
TMEM65 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.564470E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.386100E-02 |
| Normal-vs-Stage2 |
1.724410E-02 |
| Normal-vs-Stage3 |
2.062200E-01 |
| Normal-vs-Stage4 |
7.650400E-01 |
| Stage1-vs-Stage2 |
5.597000E-01 |
| Stage1-vs-Stage3 |
5.112800E-01 |
| Stage1-vs-Stage4 |
5.394000E-01 |
| Stage2-vs-Stage3 |
2.941400E-01 |
| Stage2-vs-Stage4 |
2.919000E-01 |
| Stage3-vs-Stage4 |
6.999200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.491850E-02 |
| Normal-vs-AfricanAmerican |
1.189010E-01 |
| Normal-vs-Asian |
3.430000E-01 |
| Caucasian-vs-AfricanAmerican |
5.757600E-01 |
| Caucasian-vs-Asian |
7.813600E-01 |
| AfricanAmerican-vs-Asian |
5.946000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.504400E-03 |
| Normal-vs-Female |
3.927200E-01 |
| Male-vs-Female |
2.812000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.772400E-02 |
| Normal-vs-Extreme_Weight |
1.045820E-02 |
| Normal-vs-Obese |
5.088800E-01 |
| Normal-vs-Extreme_Obese |
1.546240E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.346200E-01 |
| Normal_Weight-vs-Obese |
2.963200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.979200E-01 |
| Extreme_Weight-vs-Obese |
2.221800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.592200E-01 |
| Obese-vs-Extreme_Obese |
6.568400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.622000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.953700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.209960E-02 |
| Normal-vs-Age(81-100Yrs) |
1.976350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.123900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.676300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.563600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.126600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.255400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.071000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.346390E-02 |
| Normal-VS-Type2 PRCC |
7.444400E-04 |
| Normal-VS-KIRP CIMP |
2.871400E-01 |
| Normal-VS-Unclassified PRCC |
6.458400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.282160E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.105560E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.927800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.321800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.470200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.734000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.513700E-02 |
| Normal-vs-N1 |
7.692400E-01 |
| Normal-vs-N2 |
8.157800E-01 |
| N0-vs-N1 |
1.042380E-01 |
| N0-vs-N2 |
5.985400E-01 |
| N1-vs-N2 |
7.864000E-01 |
|
|
